With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

Vanderbilt University Medical Center's vaccine center has the antibodies to make a hantavirus vaccine. But to get it into ...

Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

The MV Hondius outbreak has renewed focus on hantavirus vaccines, with Moderna developing an mRNA-based shot. The Andes strain's high mortality rate underscores the urgency for effective solutions.

The Ebola outbreak in central Africa sparked by the rare Bundibugyo strain, for which no vaccines or therapies are licensed, ...

The team are working on testing the ChAdOx1 BDBV vaccine, a type of viral-vector vaccine that has been previously used in the ...

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...